SUTRO BIOPHARMA INC (STRO) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 298 transactions totaling $25.7M, demonstrating a bearish sentiment with -$4.2M in net insider flow. The most recent transaction on Dec 12, 2025 involved a transaction of 2,500 shares valued at $0.
No significant insider buying has been recorded for STRO in the recent period.
No significant insider selling has been recorded for STRO in the recent period.
Based on recent SEC filings, insider sentiment for STRO is bearish with an Insider Alignment Score of 42/100 and a net flow of -$4.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at SUTRO BIOPHARMA INC (STRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading STRO stock, having executed 298 transactions in the past 90 days. The most active insider is John Gordon Freund (Executive), who has made 10 transactions totaling $14.2M.
Get notified when executives and directors at STRO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Chung Jane | Executive | Option Exercise | 2,500 | $N/A | $0 | |
| Dec 12, 2025 | Chung Jane | Executive | Payment | 894 | $8.02 | $7.2K | |
| Oct 15, 2025 | Pauling David | Executive | Purchase | 12,504 | $0.80 | $10.0K | |
| Oct 15, 2025 | Matsui Connie | Executive | Purchase | 50,000 | $0.80 | $40.0K | |
| Oct 15, 2025 | Chung Jane | Executive | Purchase | 12,500 | $0.80 | $10.0K | |
| Oct 15, 2025 | K. Chow Gregory | Executive | Purchase | 19,750 | $0.81 | $16.0K | |
| Oct 15, 2025 | Gerber Hans-peter | Executive | Purchase | 17,000 | $0.80 | $13.6K | |
| Sep 18, 2025 | Gerber Hans-peter | Executive | Payment | 13,417 | $0.90 | $12.1K | |
| Sep 18, 2025 | Gerber Hans-peter | Executive | Option Exercise | 37,500 | $N/A | $0 | |
| Aug 9, 2025 | Chung Jane | Executive | Payment | 6,708 | $0.80 | $5.4K | |
| Aug 9, 2025 | Chung Jane | Executive | Option Exercise | 18,750 | $N/A | $0 | |
| Jul 8, 2025 | Leyman Barbara | Executive | Payment | 8,944 | $0.78 | $7.0K | |
| Jul 8, 2025 | Leyman Barbara | Executive | Option Exercise | 25,000 | $N/A | $0 | |
| Sep 18, 2024 | Gerber Hans-peter | Executive | Payment | 13,380 | $3.95 | $52.9K | |
| Sep 18, 2024 | Gerber Hans-peter | Executive | Option Exercise | 37,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 26 | $14.9M | 50.9% |
Purchase(P) | 10 | $10.7M | 36.6% |
Payment(F) | 86 | $3.1M | 10.4% |
Exercise(M) | 112 | $617.9K | 2.1% |
Gift(G) | 4 | $0 | 0.0% |
Other(J) | 6 | $0 | 0.0% |
Conversion(C) | 54 | $0 | 0.0% |
Insider activity at SUTRO BIOPHARMA INC shows mixed signals across all time. While $10.7M in purchases indicates some executive confidence,$14.9M in sales balances the picture, resulting in a modest net flow of -$4.2M.25 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, John Gordon Freund, has transacted $14.2M during this period.